Stratified analysis by cancer type revealed that ADH1B Arg47His polymorphism reduced risk in esophageal cancer, upper aerodigestive tract cancer, and head and neck cancer, while no effect was found on colorectal, hepatocellular, gastric and pancreatic cancer. This evidence concerns the gene ADH1B and head and neck cancer.